These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 7030887)

  • 1. Review of the hepatic response to hypolipidaemic drugs in rodents and assessment of its toxicological significance to man.
    Cohen AJ; Grasso P
    Food Cosmet Toxicol; 1981 Oct; 19(5):585-605. PubMed ID: 7030887
    [No Abstract]   [Full Text] [Related]  

  • 2. Identifying chemicals based on receptor binding/bioactivation/mechanistic explanation associated with potential to elicit hepatotoxicity and to support structure activity relationship-based read-across.
    Wu S; Daston G; Rose J; Blackburn K; Fisher J; Reis A; Selman B; Naciff J
    Curr Res Toxicol; 2023; 5():100108. PubMed ID: 37363741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable insulin-secreting ducts formed by reprogramming of cells in the liver using a three-gene cocktail and a PPAR agonist.
    Banga A; Greder LV; Dutton JR; Slack JM
    Gene Ther; 2014 Jan; 21(1):19-27. PubMed ID: 24089243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single and chronic administration of ciprofibrate or of ciprofibrate-glycinate in male Fischer 344 rats: comparison of the effects on morphological and biochemical parameters in liver and blood.
    Lupp A; Karge E; Danz M; Deufel T; Oelschläger H; Klinger W
    Eur J Drug Metab Pharmacokinet; 2005; 30(3):203-18. PubMed ID: 16250258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte proliferation induced by a single dose of a peroxisome proliferator.
    Ohmura T; Ledda-Columbano GM; Piga R; Columbano A; Glemba J; Katyal SL; Locker J; Shinozuka H
    Am J Pathol; 1996 Mar; 148(3):815-24. PubMed ID: 8774136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.
    Lake BG; Evans JG; Cunninghame ME; Price RJ
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):241-7. PubMed ID: 8013414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription.
    Aldridge TC; Tugwood JD; Green S
    Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):473-9. PubMed ID: 7887901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of clofibrate on the growth-kinetics of the murine P 1798(sc) lymphoma.
    Ubeira FM; Seoane R; Puentes E; Faro J; Regueiro BJ
    Br J Cancer; 1983 Sep; 48(3):417-21. PubMed ID: 6351886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of phthalic acid esters on the liver and thyroid.
    Hinton RH; Mitchell FE; Mann A; Chescoe D; Price SC; Nunn A; Grasso P; Bridges JW
    Environ Health Perspect; 1986 Dec; 70():195-210. PubMed ID: 3830106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic effects of phthalate esters and related compounds--in vivo and in vitro correlations.
    Lake BG; Gray TJ; Gangolli SD
    Environ Health Perspect; 1986 Aug; 67():283-90. PubMed ID: 3757955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug.
    Reddy JK; Reddy MK; Usman MI; Lalwani ND; Rao MS
    Environ Health Perspect; 1986 Mar; 65():317-27. PubMed ID: 3709457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics and subacute toxicity of di(2-ethylhexyl) phthalate (DEHP) in rats and marmosets: extrapolation of effects in rodents to man.
    Rhodes C; Orton TC; Pratt IS; Batten PL; Bratt H; Jackson SJ; Elcombe CR
    Environ Health Perspect; 1986 Mar; 65():299-307. PubMed ID: 3086078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of peroxisome proliferation and hepatic tumours in C57BL/6N mice by ciprofibrate, a hypolipidaemic compound.
    Rao MS; Dwivedi RS; Subbarao V; Reddy JK
    Br J Cancer; 1988 Jul; 58(1):46-51. PubMed ID: 2901849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependence and differential induction of rat and guinea pig peroxisomal beta-oxidation, palmitoyl-CoA hydrolase, cytosolic and microsomal epoxide hydrolase after treatment with hypolipidemic drugs.
    Oesch F; Hartmann R; Timms C; Strolin-Benedetti M; Dostert P; Wörner W; Schladt L
    J Cancer Res Clin Oncol; 1988; 114(4):341-6. PubMed ID: 2900839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple peroxisomal enzymatic deficiency disorders. A comparative biochemical and morphologic study of Zellweger cerebrohepatorenal syndrome and neonatal adrenoleukodystrophy.
    Vamecq J; Draye JP; Van Hoof F; Misson JP; Evrard P; Verellen G; Eyssen HJ; Van Eldere J; Schutgens RB; Wanders RJ
    Am J Pathol; 1986 Dec; 125(3):524-35. PubMed ID: 2879480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the peroxisome proliferator perfluorodecanoic acid on growth and lipid metabolism in Sprague Dawley rats fed three dietary levels of selenium.
    Borges T; Glauert HP; Chen LC; Chow CK; Robertson LW
    Arch Toxicol; 1990; 64(1):26-30. PubMed ID: 2306190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia.
    Balfour JA; McTavish D; Heel RC
    Drugs; 1990 Aug; 40(2):260-90. PubMed ID: 2226216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyromimetic effect of peroxisomal proliferators in rat liver.
    Hertz R; Aurbach R; Hashimoto T; Bar-Tana J
    Biochem J; 1991 Mar; 274 ( Pt 3)(Pt 3):745-51. PubMed ID: 2012603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative induction of cytochrome P450IVA1 and peroxisome proliferation by ciprofibrate in the rat and marmoset.
    Makowska JM; Bonner FW; Gibson GG
    Arch Toxicol; 1991; 65(2):106-13. PubMed ID: 1905530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of peroxisome proliferator-induced hepatocarcinogenesis.
    Rao MS; Reddy JK
    Environ Health Perspect; 1991 Jun; 93():205-9. PubMed ID: 1685443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.